TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
Earnings
TFA Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of TFA Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
TFA Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When TFA Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases TFA Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
See a number that looks wrong?